GLAND.NS
Price:
$2529.4
Market Cap:
$417.25B
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, b...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2020-11-20
Stock Exchange
NSE
Ticker
GLAND.NS
According to Gland Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 40.52. This represents a change of 28.76% compared to the average of 31.47 of the last 4 quarters.
The mean historical PE Ratio of Gland Pharma Limited over the last ten years is 46.77. The current 40.52 PE Ratio has changed 8.56% with respect to the historical average. Over the past ten years (40 quarters), GLAND.NS's PE Ratio was at its highest in in the March 2023 quarter at 66.33. The PE Ratio was at its lowest in in the March 2026 quarter at 19.05.
Average
46.77
Median
38.98
Minimum
26.73
Maximum
87.82
Discovering the peaks and valleys of Gland Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.66%
Maximum Annual PE Ratio = 87.82
Minimum Annual Increase = -41.54%
Minimum Annual PE Ratio = 26.73
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | 27.20 | -25.76% |
| 2025 | 36.64 | -5.26% |
| 2024 | 38.67 | 44.66% |
| 2023 | 26.73 | -39.71% |
| 2022 | 44.34 | 12.84% |
| 2021 | 39.29 | 7.72% |
| 2020 | 36.48 | -41.54% |
| 2019 | 62.40 | -28.94% |
| 2018 | 87.82 | 28.86% |
The current PE Ratio of Gland Pharma Limited (GLAND.NS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
34.17
5-year avg
34.72
10-year avg
46.77
Gland Pharma Limited’s PE Ratio is less than Ipca Laboratories Limited (42.02), less than Ipca Laboratories Limited (42.02), less than Ajanta Pharma Limited (40.85), less than Ajanta Pharma Limited (40.85), greater than Pfizer Limited (29.75), greater than Pfizer Limited (29.75), less than J. B. Chemicals & Pharmaceuticals Limited (53.25), less than Global Health Limited (64.33), less than J. B. Chemicals & Pharmaceuticals Limited (53.25), less than Global Health Limited (64.33),
| Company | PE Ratio | Market cap |
|---|---|---|
| 42.02 | $478.80B | |
| 42.02 | $479.55B | |
| 40.85 | $430.99B | |
| 40.85 | $431.38B | |
| 29.75 | $214.91B | |
| 29.75 | $214.91B | |
| 53.25 | $387.42B | |
| 64.33 | $358.94B | |
| 53.25 | $386.77B | |
| 64.33 | $358.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gland Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gland Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Gland Pharma Limited's PE Ratio?
How is the PE Ratio calculated for Gland Pharma Limited (GLAND.NS)?
What is the highest PE Ratio for Gland Pharma Limited (GLAND.NS)?
What is the 3-year average PE Ratio for Gland Pharma Limited (GLAND.NS)?
What is the 5-year average PE Ratio for Gland Pharma Limited (GLAND.NS)?
How does the current PE Ratio for Gland Pharma Limited (GLAND.NS) compare to its historical average?